MedTrace Logo

Cerebral Autoregulation and COVID-19

NCT04930874 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2024-12-19

No results posted yet for this study

Summary

This study aims to assess cerebral autoregulation by near-infrared spectroscopy (NIRS) in patients with severe coronavirus disease 19 (COVID-19). Results on COVID-19 participants will be compared with prior results of patients with septic shock and cardiac arrest, who participated in NCT03649633 and NCT02790788, respectively.

Conditions

Interventions

OTHER

NIRS (Near-Infrared Spectroscopy)

NIRS assessment of cerebral autoregulation and cerebral blood flow

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Principal Investigators

  • Spyros D Mentzelopoulos, MD, Professor · National and Kapodistrian University of Athens

  • Anastasia D Kotanidou, MD, Professor · National and Kapodistrian University of Athens

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-22
Primary Completion
2022-09-16
Completion
2022-09-16

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04930874 on ClinicalTrials.gov